Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

GERD

- PMLiVE

Forging a path in specialty care

Takeda’s Marc Princen on the company’s plans to build a reputation in oncology, gastroenterology and vaccine

EU forms mHealth app working group

Tasks it with drafting guidelines for assessing the validity and reliability of the data collected

Threat of medical device hacking is ‘growing concern’

FDA issues new cybersecurity guidance to help minimise risks

Novartis sets sights on connected inhaler

Plans 2019 launch for Qualcomm-partnered device

China flag thumb

AstraZeneca sets sights on China with Takeda deal

Buys the Japanese firm's respiratory drugs to extends their ongoing biologics R&D collaboration

UCB trials wearable sensor for Parkinson’s

Its medical device combines with a mobile app to measure motor symptom patterns

- PMLiVE

iPhone app helps diagnose cardiac arrhythmias

iRhythmTechnologies launches myZIO app

- PMLiVE

FDA clears Takeda’s oral multiple myeloma drug

Ninlaro is the first oral proteasome inhibitor to get a green light from the FDA

- PMLiVE

ResearchKit picked for autism, epilepsy and melanoma studies

Continues Apple's exploration of its iPhone software as amedical research tool

- PMLiVE

Allergan backs new glaucoma app

GlaucomaIn Perspective was developed by City University London

- PMLiVE

Digital technology and patient support

Programmes that improve outcomes are a key area for pharma

- PMLiVE

Takeda’s ixazomib moves closer to US approval

Wins priority review from the FDA

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links